320 related articles for article (PubMed ID: 18247352)
21. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering.
Vanegas M; Llano M; Delgado S; Thompson D; Peretz M; Poeschla E
J Cell Sci; 2005 Apr; 118(Pt 8):1733-43. PubMed ID: 15797927
[TBL] [Abstract][Full Text] [Related]
22. Measuring protein-protein interactions inside living cells using single color fluorescence correlation spectroscopy. Application to human immunodeficiency virus type 1 integrase and LEDGF/p75.
Maertens G; Vercammen J; Debyser Z; Engelborghs Y
FASEB J; 2005 Jun; 19(8):1039-41. PubMed ID: 15788449
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication.
Vandegraaff N; Devroe E; Turlure F; Silver PA; Engelman A
Virology; 2006 Mar; 346(2):415-26. PubMed ID: 16337983
[TBL] [Abstract][Full Text] [Related]
24. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
[TBL] [Abstract][Full Text] [Related]
25. Seeing is believing: structure of the catalytic domain of HIV-1 integrase in complex with human LEDGF/p75.
Bradley CM; Craigie R
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17543-4. PubMed ID: 16314581
[No Abstract] [Full Text] [Related]
26. New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays.
De Luca L; Morreale F; Christ F; Debyser Z; Ferro S; Gitto R
Eur J Med Chem; 2013 Oct; 68():405-11. PubMed ID: 23994868
[TBL] [Abstract][Full Text] [Related]
27. In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75.
McNeely M; Hendrix J; Busschots K; Boons E; Deleersnijder A; Gerard M; Christ F; Debyser Z
J Mol Biol; 2011 Jul; 410(5):811-30. PubMed ID: 21763490
[TBL] [Abstract][Full Text] [Related]
28. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site.
Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Newman J; Martyn J; Coates JA; Ede NJ; Rea P; Deadman JJ
Chembiochem; 2011 Oct; 12(15):2311-5. PubMed ID: 21850718
[TBL] [Abstract][Full Text] [Related]
30. An essential role for LEDGF/p75 in HIV integration.
Llano M; Saenz DT; Meehan A; Wongthida P; Peretz M; Walker WH; Teo W; Poeschla EM
Science; 2006 Oct; 314(5798):461-4. PubMed ID: 16959972
[TBL] [Abstract][Full Text] [Related]
31. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
Panwar U; Singh SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
[TBL] [Abstract][Full Text] [Related]
32. Study of Structure-active Relationship for Inhibitors of HIV-1 Integrase LEDGF/p75 Interaction by Machine Learning Methods.
Li Y; Wu Y; Yan A
Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28244220
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium.
Hayouka Z; Rosenbluh J; Levin A; Loya S; Lebendiker M; Veprintsev D; Kotler M; Hizi A; Loyter A; Friedler A
Proc Natl Acad Sci U S A; 2007 May; 104(20):8316-21. PubMed ID: 17488811
[TBL] [Abstract][Full Text] [Related]
34. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
Chen WM; Liu XY
Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
[TBL] [Abstract][Full Text] [Related]
35. Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay.
Hou Y; McGuinness DE; Prongay AJ; Feld B; Ingravallo P; Ogert RA; Lunn CA; Howe JA
J Biomol Screen; 2008 Jun; 13(5):406-14. PubMed ID: 18480474
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 integrase preassembled on donor DNA is refractory to activity stimulation by LEDGF/p75.
Yu F; Jones GS; Hung M; Wagner AH; MacArthur HL; Liu X; Leavitt S; McDermott MJ; Tsiang M
Biochemistry; 2007 Mar; 46(10):2899-908. PubMed ID: 17298035
[TBL] [Abstract][Full Text] [Related]
37. Effective prediction model and determination of binding residues influential for inhibitors targeting HIV-1 integrase-LEDGF/p75 interface by employing solvent accessible surface area energy as key determinant.
Thangsunan P; Wongsaipun S; Kittiwachana S; Suree N
J Biomol Struct Dyn; 2020 Feb; 38(2):460-473. PubMed ID: 30744499
[TBL] [Abstract][Full Text] [Related]
38. Calculation of binding energy using BLYP/MM for the HIV-1 integrase complexed with the S-1360 and two analogues.
Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
Bioorg Med Chem; 2007 Jun; 15(11):3818-24. PubMed ID: 17420131
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction.
Zhao Y; Luo Z
Mini Rev Med Chem; 2015; 15(14):1195-208. PubMed ID: 26156421
[TBL] [Abstract][Full Text] [Related]
40. Virtual-screening targeting Human Immunodeficiency Virus type 1 integrase-lens epithelium-derived growth factor/p75 interaction for drug development.
Gu WG; Liu BN; Yuan JF
J Drug Target; 2015 Feb; 23(2):134-9. PubMed ID: 25230778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
